Skip to main content

Advertisement

ADVERTISEMENT

News

News
02/27/2024
Starting in 2024, Medicare Part D enrollees could benefit from a cap placed on out-of-pocket drug spending, thanks to a provision in the Inflation Reduction Act of 2022 (IRA).
Starting in 2024, Medicare Part D enrollees could benefit from a cap placed on out-of-pocket drug spending, thanks to a provision in the Inflation Reduction Act of 2022 (IRA).
Starting in 2024, Medicare Part...
02/27/2024
First Report Managed Care
News
02/26/2024
The escalating concern over specialty drug costs for employers and health plan executives is driven by significant spending increases, reaching $315 billion in 2022, with specialty drugs comprising 50% of total spending despite their low...
The escalating concern over specialty drug costs for employers and health plan executives is driven by significant spending increases, reaching $315 billion in 2022, with specialty drugs comprising 50% of total spending despite their low...
The escalating concern over...
02/26/2024
First Report Managed Care
News
02/21/2024
Experts highlight the impact of the "warped incentives" in drug pricing's gross-to-net bubble, revealing that despite significant discounts, certain biosimilars are excluded from the formularies of major pharmacy benefit managers, leading to...
Experts highlight the impact of the "warped incentives" in drug pricing's gross-to-net bubble, revealing that despite significant discounts, certain biosimilars are excluded from the formularies of major pharmacy benefit managers, leading to...
Experts highlight the impact of...
02/21/2024
First Report Managed Care

Advertisement

News
02/20/2024
The 2024 Medicare physician fee schedule final rule, after evaluation using the fee schedule look-up tool and input from 2 experts, presents a mixed picture for primary care physicians (PCPs) and potential improvements for specialists, though...
The 2024 Medicare physician fee schedule final rule, after evaluation using the fee schedule look-up tool and input from 2 experts, presents a mixed picture for primary care physicians (PCPs) and potential improvements for specialists, though...
The 2024 Medicare physician fee...
02/20/2024
First Report Managed Care
News
02/16/2024
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
02/15/2024
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care

Advertisement

News
02/15/2024
Dairy and gluten intake had no substantial effects on disease activity and quality of life in a retrospective study of 186 patients with multiple sclerosis (MS). Researchers published their findings online in Multiple Sclerosis Journal –...
Dairy and gluten intake had no substantial effects on disease activity and quality of life in a retrospective study of 186 patients with multiple sclerosis (MS). Researchers published their findings online in Multiple Sclerosis Journal –...
Dairy and gluten intake had no...
02/15/2024
First Report Managed Care
News
02/14/2024
The initial findings regarding the changes in prescription drug prices for 2024 have arrived. In this summary, we’ll outline shifts and seek insights from Edmund J Pezalla, MD, founder and CEO, Enlightenment Bioconsult, examine underlying...
The initial findings regarding the changes in prescription drug prices for 2024 have arrived. In this summary, we’ll outline shifts and seek insights from Edmund J Pezalla, MD, founder and CEO, Enlightenment Bioconsult, examine underlying...
The initial findings regarding...
02/14/2024
First Report Managed Care
News
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care

Advertisement

News
02/07/2024
Brolucizumab significantly impacts choroidal morphology in eyes affected by type 1 neovascular AMD, according to a study published in Scientific Reports.
Brolucizumab significantly impacts choroidal morphology in eyes affected by type 1 neovascular AMD, according to a study published in Scientific Reports.
Brolucizumab significantly...
02/07/2024
First Report Managed Care

Advertisement